当前位置: X-MOL 学术J. Pediatr. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Uncommon Presentation of COVID-19 in Pediatric Patients: Anosmia
Journal of Pediatric Infectious Diseases ( IF 0.2 ) Pub Date : 2021-02-18 , DOI: 10.1055/s-0041-1723974
Hatice Y. Dağlı 1 , Özge M. Akcan 2 , Sevgi Pekcan 3 , Mustafa Gençeli 4 , Hüseyin S. Özdemir 4 , Betül Uğurlu 4 , Ümmü S. Özbek 4 , Havva Parlatan 4 , Fatih Akın 4 , Abdullah Yazar 4 , Ahmet O. Kılıç 4 , Mehmet Özdemir 5 , Fatma E. Taşbent 6
Affiliation  

Objective The novel coronavirus disease 2019 (COVID-19) infection was declared as a pandemic by the World Health Organization on March 11, 2020. Although the complaint of anosmia is well described in adult patients, there is limited knowledge in pediatric patients. We aim to evaluate the epidemiological characteristics and clinical findings of children with anosmia in COVID-19-positive pediatric patients.

Materials and Methods Patients diagnosed with COVID-19 infection at 1 month to 18 years of age, who admitted to Meram Faculty of Medicine of Necmettin Erbakan University between March and June 2020, were retrospectively reviewed, and the patients who had anosmia or developed anosmia during follow-up were then included in the study. The diagnosis was established by polymerase chain reaction (PCR).

Results A total of 71 patients were diagnosed with COVID-19 and 14 (19.7%) of them had anosmia. Mean patient age was 14.07 (range: 10–16) years. Six of our 14 (42.8%) patients had anosmia at the time of diagnosis and anosmia developed in the follow-up among eight patients. The mean duration of anosmia in our patients was 6.9 ± 3.8 days. Recovery time was 1 to 4 days in four patients (28.5%), 5 to 8 days in four patients (28.5%), and 9 to 14 days in six patients (42.8%).

Conclusion In this article, it was emphasized that anosmia can be the sole manifestation or concomitant with other symptoms in children with COVID-19 disease. Care and attention is important to identify COVID-19 patients at an early stage of the disease and limit the spread of the virus.



中文翻译:

小儿患者中罕见的COVID-19表现:失眠

目的 世界卫生组织于2020年3月11日宣布将新型冠状病毒病2019(COVID-19)感染宣布为大流行病。尽管成人患者对缺氧症的投诉已有很好的描述,但儿科患者的知识却有限。我们的目的是评估COVID-19阳性儿童患儿的失眠儿童的流行病学特征和临床表现。

资料与方法 回顾性分析了2020年3月至2020年6月间进入内克米汀·厄尔巴坎大学梅拉姆医学院的1月至18岁被诊断出患有COVID-19感染的患者,并回顾了在此期间患有厌食症或厌食症的患者随后将随访纳入研究。通过聚合酶链反应(PCR)确定诊断。

结果 共诊断出71例COVID-19患者,其中14例(19.7%)患有嗅觉异常。平均患者年龄为14.07岁(范围:10-16岁)。我们的14例患者中有6例(42.8%)在诊断时患有失眠症,并且在8例患者的随访中出现了失眠症。我们患者的平均嗅觉持续时间为6.9±3.8天。4名患者(28.5%)的恢复时间为1至4天,四名患者(28.5%)的恢复时间为5至8天,六名患者(42.8%)的恢复时间为9至14天。

结论 在本文中,强调了失眠可能是COVID-19病患儿的唯一表现或与其他症状同时发生。护理和注意对于在疾病的早期识别COVID-19患者和限制病毒传播很重要。

更新日期:2021-02-19
down
wechat
bug